SERPINB1 and cancer: Finally, using an exploratory two-way ANOVA that included both cancer type and patient mortality, we found significantly reduced SERPINB1 levels in non-surviving lung cancer patients in the platelet proteome data of the current 2D-DIGE study, but not in brain cancer.